The SKT - A short cognitive performance test for assessing deficits of memory and attention

International Psychogeriatrics

Volumn 9, Issue SUPPL. 1, 1997, Pages 115-121

  Lehfeld, Hartmut ^a   Erzigkeit, Hellmut ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMNESIA; ATTENTION DEFICIT DISORDER; COGNITIVE DEFECT; CONFERENCE PAPER; HUMAN; NEUROPSYCHOLOGICAL TEST; PERFORMANCE;

EID: 0031439379     PISSN: 10416102     EISSN: None     Source Type: Journal    
DOI: 10.1017/s104161029700478x     Document Type: Conference Paper

References (32)

1. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
2. Arnold, K. (1983). Untersuchungen zu Aspekten der Normierung, Reliabilität und Validität eines Testsystems zur Erfassung von Aufmerksamkeits- und Gedächtnisstörungen. Dissertation an der FAU Erlangen [Investigations concerning aspects of standardization, reliability and validity of a test instrument for assessing deficits of memory and attention]. Doctoral thesis at the University of Erlangen, Germany.
3. Arnold, K., & Heinrich, C. (1996). Parallelität der SKT-Formen A bis E [Parallelity of SKT forms A-E]. Unpublished study report.
4. Bernhardt, T., Kübler, J., & Erzigkeit, H. (1994). Hirnleistungsstörungen im Alter: Nimodipin in der niedergelassenen Praxis [Cognitive performance deficits in the elderly: Nimodipine in "General Practice"]. Kassenarzt, 31/32, 35-39.
5. Blaha, L., Erzigkeit, H., Adamczyk, A., Freytag, S., & Schaltenbrand, R. (1989). Clinical evidence of the effectiveness of vinpocetine in the treatment of organic psychosyndrome. Human Psychopharmacology, 4, 103-111.
6. Committee for Proprietary Medicinal Products (CPMP) Working Party on Efficacy of Medicinal Products (1992). Antidementia Medicinal Products: Notes for guidance (Draft 5). Commission of the European Communities, November 1992, III/3705-91-EN.
7. Dierks, T., Frölich, L., Ihl, R., & Maurer, K. (1993). Korrelation zwischen Schweregrad einer Demenz vom Alzheimer-Typ und Schwerpunkt-Dipolen der spontanen EEG-Aktivität [Correlations between severity of dementia of Alzheimer-type and spontaneous EEG activity described by equivalent dipoles]. In P. Baumann (Ed.), Biologische Psychiatrie der Gegenwart. Wien, Germany: Springer-Verlag.
8. Ditzler, K. (1991). Efficacy and tolerability of memantine in patients with dementia syndrome: A double-blind, placebo controlled trial. Arzneimittel Forschung/Drug Research, 41, 773-780.
9. Erzigkeit, H. (1989a). SKT. Ein Kurztest zur Erfassung von Gedächtnis- und Aufmerksamkeitsstörungen. 4. Auflage [SKT. A short cognitive performance test for assessing deficits of memory and attention. 4th ed.], Weinheim, Germany: Beltz.
10. Erzigkeit, H. (1989b). The SKT: A short cognitive performance test as an instrument for the assessment of clinical efficacy of cognition enhancers. In M. Bergener & B. Reisberg (Eds.), Diagnosis and treatment of senile dementia. Berlin: Springer.
11. Erzigkeit, H. (1991). The development of the SKT project. In I. Hindmarch, H. Hippius, & G. K. Wilcock (Eds.), Dementia: Molecules, methods and measures. Chichester, England: Wiley.
12. Erzigkeit, H. (1992). SKT Manual: Concise version. Witten, Germany: Geromed.
13. Fenzl, E., Apecechea, M., Schaltenbrand, R., & Friedel, R. (1986). Long term study concerning tolerance and efficacy of vinpocetine in elderly patients suffering from a mild to moderate organic psychosyndrome due to cerebral metabolic disturbances. In J. Kriegstein (Ed.), Pharmacology of cerebral ischemia. New York: Elsevier.
14. Fischhof, P. K., Wagner, G., Littschauer, L., Rüther, E., Apecechea, M., et al. (1989). Therapeutic results with nimodipine in primary degenerative dementia and multi-infarct dementia. In M. Bergener & B. Reisberg (Eds.), Diagnosis and treatment of senile dementia. Berlin: Springer.
15. Fuchs, H.-H., Erzigkeit, H., Arnold, K., & Flügel, K. A. (1980). Psychopathometrische Verlanfsuntersuchungen und Prognosen bei Patienten mit Schädel-Hirh-trauma. [Psychopathometric follow-up studies and prognosis with patients suffering from post-concussional syndrome]. In H. H. Wieck (Ed.), Neurotraumatologie. Derzeitige Schwerpunkte. Stuttgart, Germany: Thieme.
16. Herrmann, W., & Stephan, K. (1992). Moving from the question of efficacy to the question of therapeutic relevance: An exploratory reanalysis of a controlled clinical study of 130 inpatients with dementia syndrome taking piracetam. International Psychogeriatrics, 4, 25-44.
17. Hindmarch, I., Fuchs, H. H., & Erzigkeit, H. (1991). Efficacy and tolerance of vinpocetine in ambulant patients suffering from mild to moderate organic psychosyndromes. International Clinical Psychopharmacology, 6, 31-43.
18. Hoffeberth, B. (1994). The efficacy of EGb 761 in patients with senile dementia of the Alzheimer type: A double-blind, placebo-controlled study on different levels of investigation. Human Psycho-pharmacology, 9, 215-222.
19. Ihl, R., Frölich, L., Dierks, T., Martin, E. M., & Maurer, K. (1992). Differential validity of psychometric tests in dementia of the Alzheimer type. Psychiatry Research, 44, 93-106.
20. International Working Group on the Harmonizationof Dementia Drug Guidelines. (1996). Work group report: Objective psychometric tests (Draft). Work group report from the 5th international conference on Alzheimer's disease and related disorders. Osaka, Japan: Author.
21. Kanowski, S., Kinzler, E., Lehmann, E., Schweizer, A., & Kuntz, G. (1995). Confirmed clinical efficacy of actovegin in elderly patients with organic brain syndrom. Pharmacopsychiatry, 28, 125-133.
22. Kim, Y. S., Nibbelink, D. W., & Overall, J. E. (1993). Factor structure and scoring of the SKT test battery. Journal of Clinical Psychology, 49, 61-71.
23. Lang, C. (1985). Syndrom-Kurztest bei unilateralen Läsionen im Versorgungsbereich der Arteria cerebri media [SKT with patients suffering from unilateral lesions in the area of the arteria cerebri media]. Psycho, 11, 194-198.
24. Lehfeld, H., Rudinger, G., Rietz, C., Heinrich, C., Wied, V., et al. (1997). Evidence of the cross-cultural stability of the factor structure of the SKT short test for assessing deficits of memory and attention. International Psychogeriatrics, 9, 139-153.
25. Overall, J. E., & Schaltenbrand, R. (1992). The SKT neuropsychological test battery. Journal of Geriatric Psychiatry and Neurology, 5, 220-227.
26. Reisberg, B., Ferris, S. H., de Leon, M. J., & Crook, T. (1982). The Global Deterioration Scale for the assessment of primary degenerative dementia. American Journal of Psychiatry, 139, 1136-1139.
27. Schaltenbrand, R., Stahl, D., & Lehfeld, H. (1992). Überlegungen zur Akzeptanz eines psychometrischen Tests: Ein Gütekriterium? [Acceptance as a psychometric test criterion in its own right]. Münchener Medizinische Wochenschrift, 134, 693-696.
28. Schmidt-Gollas, N., & Erzigkeit, H. (1994). Ways of constructing a therapy sensitive scale for the assessment of ADL aspects of cognitively impaired elderly patients. In M. Bergener, R. H. Belmaker, & M. S. Tropper (Eds.), Psychopharmacotherapy for the elderly: Research and clinical implications. New York: Springer Publishing Company.
29. Taghavy, A., & Hamer, H. (1993). Korrelationen zwischen Parametern des visuellen P300s und Ergebnissen aus psychometrischen Testungen bei Patienten mit Hirninfarkten im Bereich der Arteria cerebri media (ein Beitrag zur Psychopathologie der ischamischen cerebrovaskulären Prozesse) [Correlations between parameters of visual P300 and psychometric test results with patients suffering from brain infarcts in the area of the arteria cerebri media]. In P. Baumann (Ed.), Biologische Psychiatrie der Gegenwart. Wien, Germany: Springer-Verlag.
30. Taghavy, A., Lang, C., Kügler, C. F. A., & Fünfgelder, J. (1990). Alterations in visual P300 in a group of Alzheimer's patients, correlated with global and subtest scores of SKT, HAWIE and WMS [Abstract]. Journal of Neurology, 237(Suppl.), 80.
31. Weyer, G., Erzigkeit, H., Hadler, D., & Kubicki, S. (1996). Efficacy and safety of idebnone in the long-term treatment of Alzheimer's disease: A double-blind, placebo controlled multicentre study. Human Psychopharmacology, 11, 53-65.
32. World Health Organization. (1992). The ICD-10 classification of mental and behavioral disorder. Geneva, Switzerland: Author.